Case Study On Zi Xin Pharmaceutical Accounting Information Disclosure Violations

Accounting information is the basis that the users learn about the financial condition and operating results of the company in order to make effective decisions. Information disclosures have a major impact on governance of listed companies, because the qualities of information disclosure can response management level of the company. As the same time, it can protect minority shareholders ’benefit, and advance the better development of capital market.In recent years, the level of information disclosure of China listed companies has improved, but there are still a lot of problems of listed company’s information disclosure. More and more listed companies’information disclosure violations are reported. Many companies are disclosed cases even relevant regulatory authorities ordered the punishment is also common occurrence, such as lack of timely disclosure of information, false statement of information, hide company insider trading; these problems will seriously damage the interests of investors and hindered the healthy and orderly development of securities market in China. Accounting Information Disclosure Violation of listing Corporation seriously influenced the investment decisions of the investors and harmed the interests of the investors. In particular, the occurring of the information disclosure irregularities, seriously strike the confidence of the investors, resulting in the credit crisis, Ander such a circumstance, the article selected is typical of the listed companies Zi Xin Pharmaceutical as the research objectives, specific framework text as follows:The first part is the introduction; this part mainly describes the background, purpose and significance, content and methods of the article. The second part describes the case, to introduce Zi Xin Pharmaceutical Company, as well as its accounting disclosure situation, Then to introduce its financial fraud cases. The third part is the case analysis, introduces the theory of information disclosure. Then analysis the issue of the company’s presence in the information disclosure, and analyze the reasons for Zi Xin Pharmaceutical to disclose violations, Provide the basis for the following recommend ations. The fourth part is the inspiration and advice. Against to the company’s accounting information disclosure violations and advance the corresponding improvement measures and suggestions. The fifth part is the conclusion.This article through the Zi Xin Pharmaceutical departure illegal disclosure of accounting information, in-depth study of induced factors behind illegal mining Zi Xin Pharmaceutical exist many defects. Reflecting the lack of company in the information disclosure problems. By combining the company’s problems for improving purple Xin Pharmaceutical accounting information disclosure quality, give specific countermeasures and suggestions in order to draw some reference to other companies.